Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 582 of 1,261
  1. US 9889156

    Method for treating noise-induced hearing loss (NIHL)

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  2. US 9889152

    Multiple PPI dosage form

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  3. US 9889137

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  4. US 9889115

    Fitness assay and associated methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  5. US 9889125

    Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  6. US 9889072

    Porous silica particle, method for producing the same, and cleansing cosmetic containing the same

    JGC Catalysts and Chemicals Ltd. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  7. US 9889071

    Calcium sulfate-resin hybrid materials and methods of using and making the same

    The Regents of the University of California · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  8. US 9888673

    Genetically modified cells, tissues, and organs for treating disease

    Regents of the University of Minnesota · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  9. US 9889070

    Curable composition

    KURARAY NORITAKE DENTAL INC. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  10. US 9890163

    Inhibitors of protein kinases

    Princeton Drug Discovery, Inc · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  11. US 9889204

    Polymeric antibiotics

    The Regents of the University of California · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  12. US 9889182

    Assisted enzyme replacement therapy

    The Regents of the University of California · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  13. US 9889160

    Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

    Precision BioSciences, Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  14. US 9889209

    Nanoconjugates able to cross the blood-brain barrier

    Northwestern University · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  15. US 9889092

    Low density lipoprotein nanocarriers for targeted delivery of omega-3 polyunsaturated fatty acids to cancer

    The Board of Regents of the University of Texas System · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  16. US 9890181

    Silicon phthalocyanine complex, preparation method and medicinal application thereof

    SHENZHEN CHINA RESOURCES GOSUN PHARMACEUTICALS CO., LTD · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  17. US 9889163

    Bioeffective krill oil compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  18. US 9890213

    Methods for the treatment of B cell-mediated inflammatory diseases

    VACCINEX, INC. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  19. US 9890212

    Antibodies to human GDF8

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  20. US 2018036436

    ETHYLENEDIAMINETETRAACETIC ACID BIS(AMIDE) DERIVATIVES AND THEIR RESPECTIVE COMPLEXES WITH MN(II) ION FOR USE AS MRI CONTRAST AGENT

    BRACCO IMAGING SPA [IT] · Granted Feb 8, 2018 · Expires Feb 3, 2038

    granted
  21. US 9885072

    High molecular weight heparosan polymers and methods of production of use thereof

    The Board of Regents of the University of Oklahoma · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  22. US 9884916

    High affinity antibodies to human IL-6 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  23. US 9884009

    Plant composition having moisturizing, anti-wrinkle, and anti-allergic efficacies, and preparation method thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  24. US 9884807

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.